| β2-microglobulin, a novel biomarker of peripheral arterial disease, independently predicts aortic stiffness in these patients. | |
| | |
MedLine Citation:
|
PMID: 21314441 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Abstract Arterial stiffness is a prominent feature of vascular ageing and strongly predicts cardiovascular and total mortality. The β2-microglobulin, (β2M) a newly identified biomarker of peripheral arterial disease (PAD), is related to renal insufficiency, inflammatory and neoplastic diseases, but may also play a role in vascular dysfunction. However, the relationship between arterial stiffness and β2M has not been previously studied in patients with atherosclerosis. In the present study we examined a possible association between β2M and arterial stiffness in patients with PAD and in healthy subjects. Plasma β2M levels and parameters of arterial stiffness such as aortic pulse wave velocity (aPWV) and augmentation index (AIx) were measured in 66 patients with PAD and in 66 apparently healthy subjects. Plasma levels of β2M, aPWV and AIx were significantly increased in patients with PAD compared with controls (1858.1 ± 472.8 vs 1554.5 ± 277.9 μg/L, p < 0.001; 9.9 ± 2.2 m/s vs 7.6 ± 1.6 m/s, p < 0.001; 28 ± 8 vs 14 ± 11%, p < 0.001; respectively). There existed significant correlation between aPWV and β2M for the patient group (R = 0.47; p < 0.001), but not for the controls (R = 0.14; p = 0.26). In multivariate analysis, β2M remained independently associated with aPWV, fetuin-A, age and glomerular filtration rate in patients (R(2) = 0.5, p < 0.001). We found no relationship between β2M and AIx in either group. We demonstrated that among patients with PAD elevated plasma β2M levels were associated with higher aortic stiffness irrespective of cardiovascular disease risk factors. These data suggest that β2M may influence the pathogenesis of aortic stiffness in atherosclerosis. |
| | |
Authors:
|
Jaak Kals; Maksim Zagura; Martin Serg; Priit Kampus; Kersti Zilmer; Eve Unt; Jüri Lieberg; Jaan Eha; Ants Peetsalu; Mihkel Zilmer |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-2-14 |
Journal Detail:
|
Title: Scandinavian journal of clinical and laboratory investigation Volume: - ISSN: 1502-7686 ISO Abbreviation: - Publication Date: 2011 Feb |
Date Detail:
|
Created Date: 2011-2-14 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0404375 Medline TA: Scand J Clin Lab Invest Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Department of Biochemistry, Centre of Excellence for Translational Medicine, University of Tartu, Tartu. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Combination of Flavonoids with Centella asiatica and Melilotus for Diabetic Cystoid Macular Edema Wi...
Next Document: 10(th) annual meeting of the Safety Pharmacology Society: an overview.